Skip to main content

IMMUCELL CORP /DE/

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 13, 2026

ICCC$10.22+4.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

June 30, 2026

Forward-Looking Statements
PART I: FINANCIAL INFORMATION
ITEM 1.Condensed Unaudited Financial Statements2
Condensed Balance Sheets as of June 30, 2026 and December 31, 20252
Condensed Statements of Income for the three and six months ended June 30, 2026 and 20253
Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2026 and 20254
Condensed Statements of Cash Flows for the six months ended June 30, 2026 and 20255-6
Notes to Condensed Unaudited Financial Statements7-15
ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations16-20
ITEM 3.Quantitative and Qualitative Disclosures about Market Risk20
ITEM 4.Controls and Procedures20
PART II: OTHER INFORMATION
ITEM 1.Legal Proceedings21
ITEM 1A.Risk Factors21
ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds21
ITEM 3.Defaults Upon Senior Securities21
ITEM 4.Mine Safety Disclosures21
ITEM 5.Other Information21
ITEM 6.Exhibits21
Signature22
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.